Cargando…
A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
BACKGROUND: Patients receiving immune checkpoint inhibitors have been reported to develop autoimmune endocrine diseases, including type 1 diabetes, although few drugs have been shown to induce type 1 diabetes. Additionally, it is important to note that drugs other than immune checkpoint inhibitors c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881334/ https://www.ncbi.nlm.nih.gov/pubmed/36703182 http://dx.doi.org/10.1186/s13256-023-03755-x |